The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Modafinil for the treatment of cocaine dependence
Open accessAbstract
Aim Modafinil was tested for efficacy in facilitating abstinence in cocaine-dependent patients, compared to placebo.Methods This was a double-blind placebo-controlled study, with 12 weeks of treatment and a 4-week follow-up. Six outpatient substance abuse treatment clinics participated in the study. There were 210 treatment-seekers randomized, having a diagnosis of cocaine dependence; 72 participants were randomized to placebo, 69 to modafinil 200mg, and 69 to modafinil 400mg, taken once daily on awakening. Participants came to the clinic three times per week for assessments and urine drug screens, and had one hour of individual psychotherapy weekly. The primary outcome measure was the weekly percentage of cocaine non-use days.Results The GEE regression analysis showed that for the total sample, there was no significant difference between either modafinil group and placebo in the change in average weekly percent of cocaine non-use days over the 12-week treatment period (p>0.79). However, two secondary outcomes showed significant effects by modafinil 200mg: the maximum number of consecutive non-use days for cocaine (p=0.02), and a reduction in craving (p=0.04). Also, a post hoc analysis showed a significant effect of modafinil that increased the weekly percentage of non-use days in the subgroup of those cocaine patients who did not have a history of alcohol dependence (p<0.02).Conclusions These data suggest that modafinil, in combination with individual behavioral therapy, was effective for increasing cocaine non-use days in participants without co-morbid alcohol dependence, and in reducing cocaine craving.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In addition, StUD is associated with moderate cognitive deficits.224”
From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [224]
Experimental — accuracy not yet measuredIn the citing paper
“Modafinil is a non-amphetamine stimulant with DA and glutamatergic effects, and with moderate effectiveness for the treatment of cocaine dependence [178] and possibly methamphetamine dependence [179].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [178]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Results from the 2003 National Survey on Drug Use and Health: National Findings
(2004) · PsycEXTRA Dataset · doi:10.1037/e400442005-001 · Cited by 1,245
Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior
Boutrel, B., Kenny, P. J., Specio, S. E., Martin-Fardon, R., Markou, A., Koob, G. F., & de Lecea, L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507480102 · Cited by 520 · cited 1×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript administration in rats (Boutrel et al., 2005).”
Hypothalamic Arousal Regions Are Activated during Modafinil-Induced Wakefulness
Scammell, T. E., Estabrooke, I. V., McCarthy, M. T., Chemelli, R. M., Yanagisawa, M., Miller, M. S., & Saper, C. B. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08620.2000 · Cited by 484 · cited 1×
“Via its actions on the hypocretin/orexin system (Scammell et al., 2000) and the glutamate/GABA (gammaAminobutyric Acid) systems (Ferraro et al., 1997) modafinil could help restore the homeostasis disturbed by chronic cocaine use.”
BackgroundA Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300600 · Cited by 391 · cited 3×
“Finally, modafinil was safe and well tolerated in Phase I interaction studies with cocaine (Donovan et al., 2005; Dackis et al., 2003), and in a pilot study on cocaine dependence treatment (n = 62) it was superior to placebo at promoting cocaine abstinence (Dackis et al., 2005).”
BackgroundMethodResultSelf-citationA pilot trial of topiramate for the treatment of cocaine dependence
Kampman, K. M., Pettinati, H. M., Lynch, K. G., Dackis, C. A., Sparkman, T., Weigley, C., & O’Brien, C. P. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.03.008 · Cited by 313 · cited 1×
“Our results are in line with those from other recent clinical trials for treatment of stimulant dependence (Kampman et al., 2004; Elkashef et al., 2008), where no single medication has been shown to help most patients, but rather, some subgroups seem to respond to a specific medication.”
ResultSelf-citationProperties of the urn randomization in clinical trials
Wei, L. J., & Lachin, J. M. (1988) · Controlled Clinical Trials · doi:10.1016/0197-2456(88)90048-7 · Cited by 308
Turner, D. C., Clark, L., Dowson, J., Robbins, T. W., & Sahakian, B. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.008 · Cited by 301 · cited 1×
“Modafinil improves cognition and mood (Turner et al., 2004; Taneja et al., 2007), and has shown efficacy in the treatment of child and adult attention deficit hyperactivity disorder (Lindsay et al., 2006).”
BackgroundBupropion for the treatment of methamphetamine dependence
Elkashef, A. M., Rawson, R. A., Anderson, A. L., Li, S.-H., Holmes, T., Smith, E. V., Chiang, N., Kahn, R., Vocci, F., Ling, W., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301481 · Cited by 234 · cited 1×
“Our results are in line with those from other recent clinical trials for treatment of stimulant dependence (Kampman et al., 2004; Elkashef et al., 2008), where no single medication has been shown to help most patients, but rather, some subgroups seem to respond to a specific medication.”
ResultSelf-citationAn evaluation of the abuse potential of modafinil using methylphenidate as a reference
Jasinski, D. R. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400107 · Cited by 234 · cited 1×
“Briefly, modafinil has stimulant properties, which could be therapeutic for alleviating some stimulant withdrawal symptoms (Malcolm et al., 2002; Jasinski, 2000), and in human laboratory test paradigms it has been found to attenuate subjective responses to cocaine (Dackis et al., 2003) and the…”
BackgroundA double-blind, placebo-controlled trial of modafinil for cocaine dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Plebani, J. G., Pettinati, H. M., Sparkman, T., & O'Brien, C. P. (2012) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.12.014 · Cited by 187
Self-citation
Research works printed but not linked: 1
- United Nations Office on Drugs and Crime, 2007. World Drug Report 2007. United Nations: New York, NY, pp. 82f.
Cited by
Sorted by citations
Items 201–238 of 238
Drug Addicts’ Decision Making Deficits: Behavioral Performance, Underlying Reasons and Interventions
刘, 洋. (2014) · Advances in Psychology · doi:10.12677/ap.2014.46110
Quisenberry, A. J., Watkins, E. E., Harvey, E. L., & Walters, J. L. (2013)
Evidence-Based Practices for Co-occurring Chemical Dependency and Mental Illness
Yuodelis‐Flores, C., Ries, R. K., & Bennett, W. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3149-7_23
Boosting impulse control in addiction. Pharmacological neuroimaging studies
Schmaal, L. (2013) · UvA-DARE (University of Amsterdam)
The effects of modafinil and atomoxetine on dopamine signaling in the striatal subregions of the rat
Bobák, M. (2015) · ISU Red - Research and eData (Illinois State University) · doi:10.30707/etd2015.bobak.m
“Additionally, phasic DA signaling has been linked to cocaine self-administration (Willuhn et al., 2014), while MOD reduces cocaine and methamphetamine administration in addicts (Anderson et al., 2009; Shearer et al., 2009).”
BackgroundDrug Addicts' Decision Making Deficits: Behavioral Performance, Underlying Reasons and Interventions
Liu, Y., Song, H., Kou, J., & Zou, Z. (2014)
Holmes, T. H., Li, S.-H., & McCann, D. J. (2016) · Statistical Methods in Medical Research · doi:10.1177/0962280216677317
Self-citationTargeting the trace amine-associated receptor 1 in psychomotor stimulant addiction.
Pei, Y. (2016) · UC Research Repository (University of Canterbury) · doi:10.26021/8251
“Clinical trials reported limited efficacy of modafinil in cocaine users, preferentially in non-alcohol dependent males (Anderson et al., 2009, Dackis et al., 2012), and in METH users 26 without other substance dependence and those attending counselling (Shearer et al., 2009).”
BackgroundCentral nervous system stimulants and drugs that suppress appetite
Sequeira, R. P. (2011) · Side effects of drugs annual · doi:10.1016/b978-0-444-53741-6.00001-5
Nuijten, M. (2017) · Data Archiving and Networked Services (DANS)
Chalwadi, P. (2016) · ISU Red - Research and eData (Illinois State University) · doi:10.30707/etd2016.chalwadi.p
Current awareness in human psychopharmacology
(2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1061
Linking Polysubstance Use, Glutamate, and the Nucleus Accumbens
Knackstedt, L. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_153-1
Attention Deficit/Hyperactivity Disorder and Substance Abuse
Levin, F. (2015) · Springer eBooks · doi:10.1007/978-88-470-5322-9_119
Linking Polysubstance Use, Glutamate, and the Nucleus Accumbens
Knackstedt, L. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_153
Pharmacological actions of commonly used drugs
Yates, J. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90578-7.00008-6
Disorders Due to Substance Use: Stimulants
Sevarino, K. A., & Farrell, M. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_26-1
Marie, N., & Noble, F. (2024) · Psychotropes · doi:10.3917/psyt.294.0105
Reinforcing Effects of the Novel Dopamine Transport Inhibitors Jjc8-088 and Jjc8-091 in MonkeysPreprint
Allen, M. I., Rahimi, O., Johnson, B., Cao, J., Newman, A. H., & Nader, M. A. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4773961
Clinical and Pharmacological Characteristics of the Drug Modafinil
Кевра, М. К., Gavrilenko, L. N., & Popov, A. S. (2023) · Рецепт · doi:10.34883/pi.2023.26.6.017
Chapter 54. Treatment of Substance Use Disorders
Sherman, B. J., Hartwell, K. J., McRae‐Clark, A. L., Herron, A., & Brady, K. T. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as54
Machine Learning Techniques for Predicting Usage of Crack Cocaine Drug
Seluguri, N., Sree, S. G., Saturi, R., Rao, M. V., Vulapula, S. R., & Arjun, N. S. (2024) · International Conference on I-SMAC (IoT in Social, Mobile, Analytics and Cloud) (I-SMAC) · doi:10.1109/i-smac61858.2024.10714783
“[1] conducted a noteworthy study revealing that income h as a complex relationship with drug use.”
BackgroundInfluentialKarila, L., Lépine, J., Coscas, S., Beck, F., & Reynaud, M. (2009) · Elsevier eBooks · doi:10.1016/b978-2-294-70316-4.00013-8
Paterson, C., Parkhouse, T., Burke, C., Halicka, M., Palmer, J. C., Gabr, H., Wilson, R., Webster, K. E., Spiga, F., Dawson, S., et al. (2025) · medRxiv · doi:10.64898/2025.12.10.25341965
Roberts, B. F., Clark, M. A., Nader, M. A., & Rough, M. I. (2026) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2026.1770940
Disruption of Dopamine Homeostasis by Psychostimulants
Torres, J., Bredenkamp, C., Vazquez, A., & Chivero, E. T. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05769-0
“…disulfiram, and modafinil’s clinical relevance as treatments for cocaine dependence appears to be context-dependent, depending on factors like whether individuals are also receiving other pharmacotherapies or behavioral therapy, and whether they use any additional drugs concurrently [213].”
Amin‐Esmaeili, M., Farokhnia, M., Mojtabai, R., Leggio, L., Johnson, R. M., & Susukida, R. (2026) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2026.1092
Paterson, C. A., Parkhouse, T., Burke, C., Halicka, M., Palmer, J. C., Gabr, H., Wilson, R. J., Webster, K. E., Spiga, F., Dawson, S., et al. (2026) · Addiction · doi:10.1111/add.70486
The use of Drosophila to study sleep impairments in stimulant use disorder
Miles, M., Karatas, M., & Rothenfluh, A. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1913395
“…and increase in treatment retention in stimulant users without other ongoing substance dependencies (Dackis et al., 2005; McGregor et al., 2008; Anderson et al., 2009; Morgan et al., 2010), though evidence is mixed for its efficacy among stimulant-users in general (Sangroula et al., 2017;…”
BindingDB (2022) · UC San Diego · doi:10.7270/q2348q2j
BindingDB (2021) · UC San Diego · doi:10.7270/q2qf8xd6
Cognitive impairment: quantification and possibilities for pharmacological treatment
Housden, C. R. (2013) · Apollo (University of Cambridge) · doi:10.17863/cam.16550
Metadata
- Authors
- Anderson, A. L., Reid, M. S., Li, S.-H., Holmes, T., Shemanski, L., Slee, A., Smith, E. V., Kahn, R., Chiang, N., Vocci, F., Ciraulo, D., Dackis, C., Roache, J. D., Salloum, I. M., Somoza, E., Urschel, H. C., & Elkashef, A. M.
- Affiliations
- National Institutes of Health (US)
- New York University (US)
- Stanford Medicine (US)
- Boston University (US)
- University of Pennsylvania (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Miami (US)
- Corresponding author
- Anderson, Ann L.
- ORCID
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 104
- Issue
- 1-2
- Pages
- 133-139
- ISSN
- 0376-8716 (ISSN-L)
- PMC
- PMC2818032
- OpenAlex
- W2140991283
- Cited by
- 235
- References
- 27
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 15 · 2023: 10 · 2022: 10 · 2021: 15 · 2020: 8 · 2019: 9 · 2018: 7 · 2017: 4 · 2016: 20 · 2015: 15 · 2014: 20 · 2013: 15 · 2012: 28
- FWCI
- 15.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Drug and Alcohol Dependence (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99 DA999999)
- National Institute on Drug Abuse (N01DA-3-8838)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- modafinil, cocaine dependence, cocaine abstinence, cocaine craving, stimulant use disorder, individual psychotherapy
- MeSH terms
- Modafinil, Adult, Alcoholism, Central Nervous System Stimulants, Benzhydryl Compounds, Combined Modality Therapy, Double-Blind Method, Ethnicity, Female, Humans, Male, Patient Compliance, Psychiatric Status Rating Scales, Psychotherapy, Risk Factors, Socioeconomic Factors, Urinalysis, Treatment Outcome, Cocaine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
